Subscribe To
Galectin therapeutics to share five scientific presentations at the liver meeting™ 2023, hosted by the aasld
Pharmacokinetics and safety of belapectin in patients with hepatic insufficiency Lack of impact of belapectin on cardiac repolarization (QT interval) ...
November 3, 2023, 12:00 pm
Samsung expects memory chip demand to improve, as operating profit beats expectations
Samsung reported its third-quarter earnings on Tuesday, beating estimates and signaling that a memory chip glu...
October 31, 2023, 12:08 am
Ironwood pharmaceuticals: the right play now
Ironwood Pharmaceuticals, Inc. is a Boston-based drug company focused on developing treatments for gastrointestinal disorders. The company's revenue-g...
October 27, 2023, 4:13 pm
Flowers foods: a healthy dividend, with shares near a strong entry point
This packaged bakery food company has a significant 17.4% share of the US bread market. It is wisely updating its brand portfolio by rotating into org...
October 24, 2023, 12:24 am
Taiwan semi beat on earnings. it's good news for intel, other chip stocks.
TSMC stock rose after it said that demand for the latest chip technology was helping to offset a glut o...
October 19, 2023, 5:58 am
Asml outlook to be key as chip-equipment maker's china sales eyed
Investors will be closely eyeing the outlook for ASML Holding, the Dutch multinational that makes the machines used to manufacture semiconductors, as ...
October 17, 2023, 4:32 am
Novo nordisk (nvo) raises sales outlook for 2023, shares gain
Novo Nordisk (NVO) increases its annual sales and operating profit forecast for the second time in 2023, driven by Ozempic (sema...
October 16, 2023, 10:32 am
Mid-america apartment communities: advantages being ignored amid supply glut
Mid-America Apartment Communities is the largest Sunbelt apartment REIT with a well-diversified portfolio and a strong balance sheet. MAA's conservati...
October 13, 2023, 8:10 am
Why dialysis stocks plunged today
Novo Nordisk shares rallied after it announced it will stop its FLOW trial nearly a year earlier than expected after positive feedback on interim data...
October 11, 2023, 12:51 pm
Samsung faces painful quarter as global memory chip glut takes hold
Plummeting memory chip demand could see Samsung Electronics (KRX:005930)' quarterly profits fall by as much as 80% year on year, according to industr...
October 10, 2023, 8:27 am
De beers slashes diamond sales to tackle gemstone market glut
De Beers on Thursday said it has slashed diamond sales in a bid to tackle a glut of gemstones in the ma...
October 5, 2023, 6:41 am
Glucose game-changers: 3 diabetes stocks to grab on the downturn
In recent months, diabetes stocks have retreated sharply, partly due to the increased popularity of the weight-loss drug Sema...
October 4, 2023, 5:53 am
3 stocks set to get pinched by the weight loss shot trend
The past few years have seen several breakthroughs in the field of weight-loss drugs, as the FDA moved to approve two new medications that promise to ...
October 2, 2023, 3:54 am
Hooker furnishings' stock tumbles toward worst day in 4 years as earnings hurt by retailers selling through ‘over-inventoried' furnishings
Shares of Hooker Furnishings Corp. HOFT, +0.61% plunged 18% in light premarket trading Friday, putting them on track for the worst one-day performance...
September 8, 2023, 6:53 am
Exclusive: china's xiaomi wins state planner nod to make evs amid glut in autos
Xiaomi Corp has won the approval of China's state planner to manufacture electric vehicles (EVs), said two people with knowledge of the matter, markin...
August 23, 2023, 2:42 am
Target's margins indicate improved inventories and upside potential, says hightower's stephanie link
Hightower Advisors' Stephanie Link joins 'Halftime Report' to discuss Target's mixed earnings results, the long term play for Target, and Target's pro...
August 16, 2023, 1:18 pm
Viatris could soon make a generic ozempic, but does that make it a buy?
Viatris is trying to get its two generic versions of semaglutide approved for sale. Novo Nordisk is sui...
August 16, 2023, 11:06 am
Why novo nordisk stock soared 16% this week
Novo Nordisk rose on news of encouraging outcomes for its SELECT trial of weight loss drug semaglutide....
August 12, 2023, 6:37 am
Novo nordisk weight loss drug impresses in heart trial
Novo Nordisk (NYSE:NVO) shares soared as the Danish pharma reported its new treatment Wegovy reduced heart problems well as weight in on ongoing trial...
August 8, 2023, 9:38 am
Novo nordisk says wegovy reduced risk of adverse cardiovascular events by 20% in adults with obesity in trial
Novo Nordisk's U.S.-listed stock NVO, +3.04% NOVO.B, +10.32% rose 10% premarket Tuesday, after the company said its obesity treatment sema...
August 8, 2023, 6:19 am